We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.6B
AUM Growth
+$1.7B
(+3.6%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
16.96%
Holding
3,019
New
199
Increased
1,870
Reduced
823
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
Microsoft
MSFT
|
+$29.1M |
| 3 |
Evergy
EVRG
|
+$26.2M |
| 4 |
Amazon
AMZN
|
+$25.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$130M |
| 2 |
MON
Monsanto Co
MON
|
+$88.9M |
| 3 |
Apple
AAPL
|
+$21.2M |
| 4 |
Keurig Dr Pepper
KDP
|
+$18.4M |
| 5 |
Gilead Sciences
GILD
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.45% |
| 2 | Financials | 16.24% |
| 3 | Healthcare | 13.05% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.44M | ﹤0.01% |
94,318
-7,910
| -8% | -$141K |
|
1852
1st Source
SRCE
$2.18B
| $1.43M | ﹤0.01% |
26,837
-109
| -0.4% | -$5.82K |
|
1853
Evolent Health
EVH
$359M
| $1.43M | ﹤0.01% |
68,036
+10,113
| +17% | +$191K |
|
1854
Regis Corp
RGS
$67.5M
| $1.43M | ﹤0.01% |
4,326
-52
| -1% | -$16.9K |
|
1855
CorVel
CRVL
$3.1B
| $1.43M | ﹤0.01% |
79,146
+57
| +0.1% | +$982 |
|
1856
Donnelley Financial Solutions
DFIN
$1.19B
| $1.42M | ﹤0.01% |
82,009
+3,854
| +5% | +$66.3K |
|
1857
Rush Enterprises Class A
RUSHA
$6.27B
| $1.42M | ﹤0.01% |
73,811
-929
| -1% | -$17.6K |
|
1858
Usana Health Sciences
USNA
$418M
| $1.42M | ﹤0.01% |
12,340
+1,685
| +16% | +$184K |
|
1859
Herc Holdings
HRI
$5.42B
| $1.41M | ﹤0.01% |
25,081
+542
| +2% | +$31.6K |
|
1860
Kearny Financial
KRNY
$614M
| $1.4M | ﹤0.01% |
104,252
+19,361
| +23% | +$269K |
|
1861
Artisan Partners
APAM
$2.96B
| $1.4M | ﹤0.01% |
46,455
+4,719
| +11% | +$153K |
|
1862
Cato Corp
CATO
$68.9M
| $1.4M | ﹤0.01% |
56,882
-1,570
| -3% | -$30.9K |
|
|
BMCH
1863
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.4M | ﹤0.01% |
67,158
+2,652
| +4% | +$52.6K |
|
1864
MYR Group
MYRG
$5.32B
| $1.4M | ﹤0.01% |
39,337
+206
| +0.5% | +$7.28K |
|
|
IPHI
1865
DELISTED
INPHI CORPORATION
IPHI
| $1.39M | ﹤0.01% |
42,718
+1,415
| +3% | +$46.2K |
|
|
SGMO
1866
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.39M | ﹤0.01% |
97,760
+18,815
| +24% | +$313K |
|
|
TWNK
1867
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.39M | ﹤0.01% |
102,057
+22,588
| +28% | +$311K |
|
|
AIMC
1868
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.38M | ﹤0.01% |
32,080
+2,160
| +7% | +$94.4K |
|
|
EGL
1869
DELISTED
Engility Holdings, Inc.
EGL
| $1.38M | ﹤0.01% |
45,032
+1,432
| +3% | +$40.9K |
|
1870
TriMas Corp
TRS
$1.44B
| $1.38M | ﹤0.01% |
46,766
+1,015
| +2% | +$28.8K |
|
|
SRG
1871
Seritage Growth Properties
SRG
$137M
| $1.37M | ﹤0.01% |
32,324
+5,901
| +22% | +$230K |
|
1872
Myers Industries
MYE
$1.38B
| $1.37M | ﹤0.01% |
71,260
+13,842
| +24% | +$295K |
|
|
TIER
1873
DELISTED
TIER REIT, Inc.
TIER
| $1.37M | ﹤0.01% |
57,506
+2,093
| +4% | +$43.6K |
|
|
FIT
1874
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.36M | ﹤0.01% |
208,891
+16,600
| +9% | +$94.9K |
|
1875
Amphastar Pharmaceuticals
AMPH
$885M
| $1.36M | ﹤0.01% |
89,343
+6,191
| +7% | +$108K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, RhumbLine Advisers held 3,019 positions worth $49.6B, up 3.6% from $47.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2018 filing shows 199 new, 1,870 increased, 823 reduced and 112 closed positions. Its largest new stake was Evergy: 490,078 shares worth $27.5M. The largest sale was Time Warner Inc, an estimated $130M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2018 buy was Evergy: 490,078 shares worth $27.5M.
- RhumbLine Advisers added most to AT&T in Q2 2018, an estimated $61.6M increase.
- RhumbLine Advisers's biggest Q2 2018 reduction was Apple, cutting an estimated $21.2M.
- RhumbLine Advisers fully exited Time Warner Inc in Q2 2018, selling an estimated $130M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $49.6B portfolio in Q2 2018.
- RhumbLine Advisers opened 199 new positions and closed 112 in Q2 2018.
- RhumbLine Advisers's portfolio value rose 3.6% quarter-over-quarter to $49.6B.
Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.